Alcohol-Linked Liver Cancer Deaths Reverse Course After Pandemic Disruptions, Study Finds
Alcohol-linked liver cancer deaths reversed course during the pandemic, new global data show, raising concern over screening delays.
The latest news on cancer screening, diagnosis and treatment, including new therapies, NHS services and research into prevention.
New Evidence Sheds Light on Cancer Cachexia Mechanism in Breakthrough Study
New research identifies a mechanism behind cancer cachexia, offering fresh hope for better treatment of the wasting condition.
NHS to Invite 500,000 Men Into Major Prostate Cancer Research Programme
NHS England will invite 500,000 men to join a major prostate cancer research programme aimed at earlier detection.
NHS Launches Major Prostate Cancer Research Drive as MenB Vaccination Boost Reaches Thousands
NHS launches a major prostate cancer research drive as MenB vaccination uptake among young people surges.
NHS Approves New Blood Cancer Drug for Children and Adults as July Reaches a Strong Finish
NHS England approves a new treatment policy for relapsed classical Hodgkin lymphoma as cancer care activity hits record levels.
NICE Recommends First NHS Treatment in Over 20 Years for Resistant Ovarian Cancer
NICE recommends mirvetuximab soravtansine, the first NHS treatment in over 20 years for resistant ovarian cancer.
NICE Backs New Bile Duct Cancer Treatment as NHS Access Expands
NICE recommends zanidatamab for advanced bile duct cancer, offering a new NHS treatment option for eligible patients in England.
AI Model Detects Hidden Pancreatic Cancer on Routine Scans, Raising Early Diagnosis Hopes
An AI model may detect hidden pancreatic cancer on routine CT scans earlier, offering hope for faster diagnosis and treatment.
NHS Rolls Out 60-Second Pembrolizumab Injection for Thousands of Cancer Patients
NHS rolls out a 60-second pembrolizumab injection for thousands of cancer patients in England, cutting treatment time and hospital visits.
BRCA Findings Point to New Risk Signals in Head and Neck Cancer
New research links BRCA variants to head and neck cancer risk, expanding the potential role of genetic testing.
